S-217622, with the CAS number 1471484-62-4, is a chemical compound that has garnered attention in pharmaceutical research, particularly for its potential therapeutic applications. It is classified as a small molecule and is known to interact with specific biological targets, which may include receptors or enzymes involved in various physiological processes. The compound's structure typically features functional groups that contribute to its biological activity, although detailed structural information is often proprietary or not widely published. S-217622 has been investigated for its efficacy in treating certain conditions, potentially including neurological or psychiatric disorders, but comprehensive data on its pharmacokinetics, toxicity, and mechanism of action may still be under study. As with many investigational compounds, further research is necessary to fully elucidate its characteristics, including its solubility, stability, and interaction with other substances. Overall, S-217622 represents a promising area of exploration within medicinal chemistry and drug development.

S-217622

1471484-62-4: S-217622, with the CAS number 1471484-62-4, is a chemical compound that has garnered attention in pharmaceutical research, particularly for its potential therapeutic applications. It is classified as a small molecule and is known to interact with specific biological targets, which may include receptors or enzymes involved in various physiological processes. The compound's structure typically features functional groups that contribute to its biological activity, although detailed structural information is often proprietary or not widely published. S-217622 has been investigated for its efficacy in treating certain conditions, potentially including neurological or psychiatric disorders, but comprehensive data on its pharmacokinetics, toxicity, and mechanism of action may still be under study. As with many investigational compounds, further research is necessary to fully elucidate its characteristics, including its solubility, stability, and interaction with other substances. Overall, S-217622 represents a promising area of exploration within medicinal chemistry and drug development.

SARS-CoV 3CL Inhibitor 1

YH-53: potent inhibitor for SARS-CoV-1 (Ki=6.3 nM) & SARS-CoV-2 3CLpro (Ki=34.7 nM); hinders SARS-CoV-2 replication; aids COVID-19 research.

CAS 1471484-62-4

S-217622

SARS-CoV 3CL Inhibitor 1

Ref: 4Z-C-348001

YH-53

Ref: TM-T9686